About
Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.
Tags
Total Employees
16
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
30Traction
12Team
0Visibility
28Profile
60Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does EdiTy Therapeutics do?
Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.
When was EdiTy Therapeutics founded?
EdiTy Therapeutics was founded in 2020.
What industry does EdiTy Therapeutics operate in?
EdiTy Therapeutics operates in Life Sciences, Immunology, Biotech, Genome Editing.
How many employees does EdiTy Therapeutics have?
EdiTy Therapeutics has approximately 16 people on record.